186 related articles for article (PubMed ID: 36553569)
1. Biomarker Discovery for Meta-Classification of Melanoma Metastatic Progression Using Transfer Learning.
Miñoza JMA; Rico JA; Zamora PRF; Bacolod M; Laubenbacher R; Dumancas GG; de Castro R
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553569
[TBL] [Abstract][Full Text] [Related]
2. Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
Li Y; Li M; Shats I; Krahn JM; Flake GP; Umbach DM; Li X; Li L
PLoS One; 2019; 14(6):e0218067. PubMed ID: 31199813
[TBL] [Abstract][Full Text] [Related]
3. Identification of a gene signature for discriminating metastatic from primary melanoma using a molecular interaction network approach.
Metri R; Mohan A; Nsengimana J; Pozniak J; Molina-Paris C; Newton-Bishop J; Bishop D; Chandra N
Sci Rep; 2017 Dec; 7(1):17314. PubMed ID: 29229936
[TBL] [Abstract][Full Text] [Related]
4. Novel oxidative stress-related prognostic biomarkers for melanoma associated with tumor metastasis.
Wu X; Zhao J
Medicine (Baltimore); 2021 Feb; 100(8):e24866. PubMed ID: 33663112
[TBL] [Abstract][Full Text] [Related]
5. Role of Elevated
Bezrookove V; Nosrati M; Miller JR; De Semir D; Dar AA; Vosoughi E; Vaquero E; Sucker A; Lazar AJ; Gershenwald JE; Davies MA; Schadendorf D; Kashani-Sabet M
Clin Cancer Res; 2018 Sep; 24(17):4119-4125. PubMed ID: 29776954
[No Abstract] [Full Text] [Related]
6. Toward predicting metastatic progression of melanoma based on gene expression data.
Li Y; Krahn JM; Flake GP; Umbach DM; Li L
Pigment Cell Melanoma Res; 2015 Jul; 28(4):453-63. PubMed ID: 25847062
[TBL] [Abstract][Full Text] [Related]
7. Prognostic score model-based signature genes for predicting the prognosis of metastatic skin cutaneous melanoma.
Wang J
Math Biosci Eng; 2021 Jun; 18(5):5125-5145. PubMed ID: 34517481
[TBL] [Abstract][Full Text] [Related]
8. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
9. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.
Han W; Huang B; Zhao XY; Shen GL
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786
[TBL] [Abstract][Full Text] [Related]
10. A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis.
Zhao Y; Schaafsma E; Gorlov IP; Hernando E; Thomas NE; Shen R; Turk MJ; Berwick M; Amos CI; Cheng C
Mol Cancer Res; 2019 Jan; 17(1):109-119. PubMed ID: 30171176
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma.
Wouters J; Vizoso M; Martinez-Cardus A; Carmona FJ; Govaere O; Laguna T; Joseph J; Dynoodt P; Aura C; Foth M; Cloots R; van den Hurk K; Balint B; Murphy IG; McDermott EW; Sheahan K; Jirström K; Nodin B; Mallya-Udupi G; van den Oord JJ; Gallagher WM; Esteller M
BMC Med; 2017 Jun; 15(1):101. PubMed ID: 28578692
[TBL] [Abstract][Full Text] [Related]
12. Is nonmetastatic cutaneous melanoma predictable through genomic biomarkers?
Branca M; Orso S; Molinari RC; Xu H; Guerrier S; Zhang Y; Mili N
Melanoma Res; 2018 Feb; 28(1):21-29. PubMed ID: 29194095
[TBL] [Abstract][Full Text] [Related]
13. The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma.
Huang R; Li M; Zeng Z; Zhang J; Song D; Hu P; Yan P; Xian S; Zhu X; Chang Z; Zhang J; Guo J; Yin H; Meng T; Huang Z
Cancer Control; 2022; 29():10732748211051554. PubMed ID: 34986671
[TBL] [Abstract][Full Text] [Related]
14. Expression and clinical significance of S100 family genes in patients with melanoma.
Xiong TF; Pan FQ; Li D
Melanoma Res; 2019 Feb; 29(1):23-29. PubMed ID: 30216200
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of autophagy-related-gene biomarker and nomogram for predicting the survival of cutaneous melanoma.
Wan Q; Jin L; Su Y; Liu Y; Li C; Wang Z
IUBMB Life; 2020 Jul; 72(7):1364-1378. PubMed ID: 32080971
[TBL] [Abstract][Full Text] [Related]
16. Prediction and Analysis of Skin Cancer Progression using Genomics Profiles of Patients.
Bhalla S; Kaur H; Dhall A; Raghava GPS
Sci Rep; 2019 Oct; 9(1):15790. PubMed ID: 31673075
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr Virus-induced Gene 3 as a Novel Biomarker in Metastatic Melanoma With Infiltrating CD8
Yonekura S
Anticancer Res; 2022 Jan; 42(1):511-517. PubMed ID: 34969761
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers.
Ross CL; Kaushik S; Valdes-Rodriguez R; Anvekar R
J Cell Physiol; 2018 Jul; 233(7):5133-5141. PubMed ID: 29226953
[TBL] [Abstract][Full Text] [Related]
20. Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden.
Lin J; Lin Y; Huang Z; Li X
Comput Math Methods Med; 2020; 2020():8836493. PubMed ID: 33273963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
